1. Online Medical Assessment
2. Program Selection & Consultation
The Process
How it works
Step 1: Assessment
Complete a short health questionnaire
Complete a short online health questionnaire so we can assess your suitability and goals.
Step 2: Consultation
Program selection & consultation
Select your program and finalise your treatment plan with your doctor.
Step 3: Treatment
Start your transformation
Start your program with regular follow ups and treatment adjustments for ongoing support.
GLP-1 & peptide therapies explained
How GLP-1s and Weight Loss Peptides Work
GLP-1 and peptide therapies are prescription treatments that support medically guided weight loss by regulating appetite and digestion. They help reduce hunger, control cravings, and slow gastric emptying so you feel fuller for longer.
Alongside this, peptide treatments can help enhance fat metabolism and preserve or gain lean muscle during weight loss.
Together, these therapies make it easier to maintain a reduced-calorie intake consistently over time, supporting improved body composition compared to traditional weight loss approaches.
The result is improved appetite control, better adherence, and more sustainable fat loss.
All treatments require a medical consultation and eligibility assessment before prescribing.
Programs
Program options
Choose the program that best matches your needs, level of medical support, and treatment goals.
Medical Consultation
Weight Loss Medication Consultation
A one-off consultation to assess suitability for prescription weight loss treatments and provide clinical guidance for patients with an existing weight loss plan.
-
Medical assessment for weight loss medications (e.g. GLP-1s)
-
Review of current health, medications, and contraindications
-
Clinician-led prescribing
-
Suitable for patients with an existing diet and exercise plan
-
No structured program or ongoing coaching
12-Week Program
Online Weight Loss Program
A 12-week remote medical weight loss programme with personalised support and treatment.
-
Personalised nutrition plan
-
Exercise guidance
-
Medical weight loss treatment plan
-
Remote doctor check-ins
-
Digital prescriptions
-
Ongoing support
-
Monthly extension available
12-Week Program
In-Person Weight Loss Program
A 12-week clinic-based programme with in-person medical supervision and monitoring.
-
4 in-clinic consultations
-
Body composition tracking
-
Medical treatment plan
-
Clinic-dispensed medication (if appropriate)
-
Progress monitoring & adjustments
-
Direct clinical support
-
Monthly extension available
Suitable for you
-
Looking for sustainable weight loss
-
Struggling with appetite or cravings
-
Weight loss has plateaued despite efforts
-
Open to structured medical support
Not suitable for you
-
Looking for rapid or extreme weight loss
-
Expecting quick results without structure
-
Not willing to follow a guided program
-
Prefer diet only approaches without additional support
The patients
Who this is for
The programs are suitable for individuals seeking structured, medically supervised weight loss support. It is designed for those who want a clear, guided approach rather than trying to manage weight loss or medication alone.
FAQs
GLP-1 & peptide FAQs
We primarily use clinically approved GLP-1 therapies such as semaglutide (e.g. Ozempic, Wegovy) and tirzepatide (e.g. Mounjaro), where medically appropriate.
In some cases, we may include supportive peptide-based protocols as part of a broader medical plan. These are used to support recovery, metabolic function, and overall treatment outcomes where clinically appropriate.
Common side effects may include nausea, reduced appetite, bloating, or mild gastrointestinal changes, especially during dose adjustments. Most effects are temporary and improve over time.
Weight loss varies, but a typical target range is around 0.5% to 1.5% of body weight per week, primarily from fat loss when combined with appropriate lifestyle support.
Compounded medications are prescription treatments prepared by licensed pharmacies based on a doctor’s instructions. They may be used when clinically appropriate and can offer a more cost-effective option compared to standard branded medications.
Treatment duration varies. Some patients transition to maintenance phases, while others continue longer under medical supervision depending on their goals and response.
Most GLP-1 medications are administered weekly, but exact dosing schedules depend on the specific medication and individual treatment plan.
Retatrutide is still in clinical development and not yet approved for general medical use. We only use clinically appropriate, regulated treatments prescribed under medical supervision.
Have a question? We’re here to help!
For general enquiries, please complete the form below and we’ll get back to you